NBT Bank’s iShares Biotechnology ETF IBB Stock Holding History

NBT Bank’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.98M	Sell	23,588 -1,049	-4%	-$179K	0.26%	95
2025 Q4	$4.16M	Sell	24,637 -318	-1%	-$51.6K	0.27%	88
2025 Q3	$3.6M	Sell	24,955 -92	-0.4%	-$12.6K	0.23%	103
2025 Q2	$3.17M	Sell	25,047 -3,244	-11%	-$398K	0.22%	107
2025 Q1	$3.62M	Sell	28,291 -689	-2%	-$93.4K	0.26%	94
2024 Q4	$3.83M	Sell	28,980 -280	-1%	-$39.4K	0.27%	93
2024 Q3	$4.26M	Sell	29,260 -214	-0.7%	-$31K	0.29%	85
2024 Q2	$4.05M	Sell	29,474 -849	-3%	-$113K	0.29%	85
2024 Q1	$4.16M	Sell	30,323 -514	-2%	-$70.2K	0.3%	82
2023 Q4	$4.19M	Sell	30,837 -155	-0.5%	-$18.9K	0.33%	72
2023 Q3	$3.79M	Sell	30,992 -960	-3%	-$122K	0.36%	63
2023 Q2	$4.06M	Sell	31,952 -257	-0.8%	-$33.4K	0.58%	47
2023 Q1	$4.16M	Sell	32,209 -2,772	-8%	-$363K	0.61%	47
2022 Q4	$4.59M	Sell	34,981 -961	-3%	-$124K	0.67%	43
2022 Q3	$4.2M	Buy	35,942 +103	+0.3%	+$12.8K	0.69%	43
2022 Q2	$4.22M	Sell	35,839 -1,121	-3%	-$133K	0.64%	46
2022 Q1	$4.82M	Sell	36,960 -284	-0.8%	-$37K	0.64%	47
2021 Q4	$5.68M	Sell	37,244 -224	-0.6%	-$34.7K	0.73%	41
2021 Q3	$6.06M	Sell	37,468 -302	-0.8%	-$50.8K	0.84%	34
2021 Q2	$6.18M	Sell	37,770 -306	-0.8%	-$47.1K	0.85%	34
2021 Q1	$5.73M	Buy	38,076 +42	+0.1%	+$6.67K	0.82%	36
2020 Q4	$5.76M	Buy	38,034 +519	+1%	+$74.2K	0.88%	32
2020 Q3	$5.08M	Sell	37,515 -194	-0.5%	-$26.3K	0.85%	31
2020 Q2	$5.16M	Sell	37,709 -357	-0.9%	-$45.5K	0.92%	29
2020 Q1	$4.1M	Buy	38,066 +768	+2%	+$88.4K	0.84%	33
2019 Q4	$4.5M	Buy	37,298 +1,202	+3%	+$134K	0.71%	39
2019 Q3	$3.59M	Sell	36,096 -1,644	-4%	-$172K	0.63%	50
2019 Q2	$4.12M	Sell	37,740 -954	-2%	-$101K	0.74%	40
2019 Q1	$4.33M	Sell	38,694 -1,566	-4%	-$172K	0.79%	36
2018 Q4	$3.88M	Sell	40,260 -3,466	-8%	-$368K	0.63%	43
2018 Q3	$5.33M	Sell	43,726 -7,932	-15%	-$934K	0.86%	35
2018 Q2	$5.67M	Sell	51,658 -22,572	-30%	-$2.41M	1.02%	29
2018 Q1	$7.92M	Sell	74,230 -1,850	-2%	-$205K	1.3%	19
2017 Q4	$8.12M	Sell	76,080 -792	-1%	-$84.7K	1.28%	21
2017 Q3	$8.55M	Sell	76,872 -2,601	-3%	-$278K	1.37%	19
2017 Q2	$8.21M	Sell	79,473 -4,497	-5%	-$443K	1.34%	20
2017 Q1	$8.21M	Sell	83,970 -333	-0.4%	-$31.9K	1.36%	21
2016 Q4	$7.46M	Sell	84,303 -1,800	-2%	-$164K	1.28%	22
2016 Q3	$8.31M	Sell	86,103 -1,230	-1%	-$117K	1.45%	19
2016 Q2	$7.49M	Buy	87,333 +438	+0.5%	+$39.3K	1.31%	24
2016 Q1	$7.55M	Sell	86,895 -1,737	-2%	-$155K	1.33%	21
2015 Q4	$10M	Sell	88,632 -2,385	-3%	-$259K	1.79%	13
2015 Q3	$9.2M	Sell	91,017 -15,678	-15%	-$1.88M	1.72%	13
2015 Q2	$13.1M	Sell	106,695 -1,734	-2%	-$208K	2.14%	6
2015 Q1	$12.4M	Sell	108,429 -1,146	-1%	-$126K	1.98%	8
2014 Q4	$11.1M	Sell	109,575 -2,079	-2%	-$202K	1.74%	13
2014 Q3	$10.2M	Sell	111,654 -8,697	-7%	-$763K	1.63%	14
2014 Q2	$10.3M	Sell	120,351 -16,431	-12%	-$1.29M	1.56%	14
2014 Q1	$10.8M	Sell	136,782 -4,017	-3%	-$335K	1.56%	14
2013 Q4	$10.7M	Sell	140,799 -4,347	-3%	-$308K	1.53%	14
2013 Q3	$10.1M	Sell	145,146 -9,312	-6%	-$610K	1.51%	14
2013 Q2	$8.95M	Buy	+154,458	New	+$8.93M	1.34%	18

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NBT Bank's IBB Position: Q1 2026 in Review

NBT Bank reduced its iShares Biotechnology ETF (IBB) stake by 4.3% in Q1 2026, selling an estimated $179K and leaving 23,588 shares worth $3.98M. The position accounts for 0.26% of the portfolio, ranked #95.

NBT Bank first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.1M in Q2 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

NBT Bank held 23,588 shares of iShares Biotechnology ETF worth $3.98M as of Q1 2026.
NBT Bank sold 1,049 iShares Biotechnology ETF shares in Q1 2026, an estimated $179K.
iShares Biotechnology ETF made up 0.26% of NBT Bank's portfolio in Q1 2026, its #95 holding.
NBT Bank first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
NBT Bank's iShares Biotechnology ETF position peaked at $13.1M in Q2 2015.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.